Sanket Koul

Draft rules scrap provisional ethics committee registration stage

Health Ministry proposes removing provisional registration for ethics committees, shifting to single-stage approval to streamline clinical research and cut regulatory delays

US-Bangladesh pact unlikely to impact India's pharma, medtech exports

Industry executives say the US-Bangladesh reciprocal trade agreement is unlikely to materially affect India's pharma and medtech exports, given India's scale and established FDA-approved supply chains

CBSE announces digital evaluation of Class 12 board papers from Feb 17

CBSE has announced the introduction of on-screen marking for Class 12 board exams from February 17, aiming to improve efficiency, transparency and reduce time and logistical costs

Fortis, IHH launch innovation platform for medtech, healthtech startups

IHH Healthcare and Fortis Healthcare have launched IHH Catalyst, a national platform to help execution-ready medtech and healthtech startups move from pilots to hospital adoption and scale

Noida sheds insolvency-hit budget market tag as luxury housing rises

Revised FAR/FSI limits, height relaxations lead to increased investor interest

Medtech manufacturing industry divided on policy for refurbished devices

Domestic device makers warn of safety and dumping risks, while MNC bodies back affordability benefits as the Centre reviews policy on refurbished high-end medical device imports

Budget announcements to position India as value-led biopharma ecosystem

Pharma-focused Budget 2026 measures could help India move beyond generics by boosting biologics, biosimilars, regulatory capacity and early-stage innovation, analysts say

Only 34% of day care cancer centres approved for FY26 are functional

Just 102 of the 297 day care cancer centres approved for FY26 are operational so far, with states such as Telangana, Bihar and Karnataka reporting a higher share of functional facilities

India's med school paradox: PG seats lie vacant amid specialist shortage

Doctors also point to declining professional dignity, workplace violence and medico-legal vulnerability as deterrents

India-US trade deal: Pharma sees no major change during Section 232 probe

India's pharmaceutical exports to the US are unlikely to see major tariff changes under the interim pact as Section 232 investigations continue, though medical devices may gain from better access

RBI nod to direct bank lending to Reits may expedite asset growth

Industry executives note that REITs raise debt by issuing securities subscribed to by mutual funds and non-banking financial companies (NBFCs)

India may need 2.7 bn sq ft of new academic infrastructure by 2035

India's higher education sector could require nearly 30,000 acres of new campus land and 2.7 billion sq ft of academic infrastructure by 2035, driven by rising enrolments and policy ambitions

Max Healthcare Q3 PAT up 26%, revenue rises 10% despite margin compression

Max Healthcare's Q3 profit rose 26% on higher occupancies and overseas patients, even as margins narrowed due to regulatory changes and expansion costs

Centre mandates drug cos to submit post-approval changes for new drugs

Draft amendment seeks mandatory reporting of manufacturing and quality changes to drug regulator

Medanta Q3FY26 PAT falls 33.5% on labour laws, Noida hospital costs

Depreciation, finance costs from new Noida facility and one-time labour code impact weigh on December-quarter profit

Housing ministry raises EWS housing target under PMAY 2.0 by 350%

Targeted housing under BLC component raised from 111,000 to 500,000 homes in FY27

Delhi emerges as world's most cost competitive student city: Report

Younger demography, infra potential prime India's push to be most strategic higher education growth market globally

Mankind Pharma Q3 PAT up 9.5%, revenue rises 11.5% on chronic drugs sales

Mankind Pharma posted a 9.5 per cent rise in Q3FY26 net profit and 11.5 per cent growth in revenue, driven by strong domestic demand for chronic therapies

Budget 2026: Pharma dept prescribes PLI boost for bulk drug output

FY27 PLI scheme allocation rises 2.24%, aiming to add 500 MT to domestic API production

Budget 2026: Govt targets 30 mn hospital admissions under PMJAY in FY27

The health ministry is targeting a sharp rise in hospital admissions and claims disbursal under PMJAY in FY27, even as the Budget provides only a marginal increase in the scheme's overall allocation